Development asset linked to Cartesian Therapeutics in public FDA and regional records.
pharma · Multiple Myeloma · generalized myasthenia gravis · RNAC
Cartesian Therapeutics
Cartesian Therapeutics drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
7495 New Horizon Way, Frederick, Maryland 21703, US HQ
2016 Founded
89 Employees
Public company Type
RNAC · NYSE Ticker
Company details
- Status
- Public
- HQ
- 7495 New Horizon Way, Frederick, Maryland 21703, US
- Founded
- 2016
- Employees
- 89
- Programs
- 12
- Drugs
- 4
- Patents
- 4
Cartesian Therapeutics pipeline
Portfolio lens on 4 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Cartesian Therapeutics drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Cartesian Therapeutics in public FDA and regional records.
-
Development asset linked to Cartesian Therapeutics in public FDA and regional records.
-
Development asset linked to Cartesian Therapeutics in public FDA and regional records.